We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Walker & Dunlop
WD
$1.71B
| $2.37M | 0.01% |
56,905
+16,693
| +42% | +$615K |
|
|
RGC
1452
DELISTED
Regal Entertainment Group
RGC
| $2.37M | 0.01% |
104,770
+3,961
| +4% | +$87.4K |
|
|
CNSL
1453
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.36M | 0.01% |
100,924
+29,048
| +40% | +$723K |
|
1454
HEICO Corp
HEI
$49.8B
| $2.36M | 0.01% |
66,121
+577
| +0.9% | +$19.2K |
|
1455
Prothena Corp
PRTA
$425M
| $2.36M | 0.01% |
42,326
+1,890
| +5% | +$99.3K |
|
|
NCI
1456
DELISTED
Navigant Consulting, Inc.
NCI
| $2.36M | 0.01% |
103,284
+25,516
| +33% | +$609K |
|
|
SYKE
1457
DELISTED
SYKES Enterprises Inc
SYKE
| $2.35M | 0.01% |
80,026
+21,823
| +37% | +$622K |
|
|
MAGN
1458
Magnera Corp
MAGN
$472M
| $2.35M | 0.01% |
8,317
+1,968
| +31% | +$588K |
|
1459
PBF Energy
PBF
$8.57B
| $2.35M | 0.01% |
105,792
+13,633
| +15% | +$320K |
|
1460
News Corp Class B
NWS
$16.9B
| $2.34M | 0.01% |
173,266
-1,798
| -1% | -$23.2K |
|
|
LNW
1461
DELISTED
Light & Wonder
LNW
| $2.33M | 0.01% |
98,733
+27,970
| +40% | +$540K |
|
|
CBL
1462
DELISTED
CBL& Associates Properties, Inc.
CBL
| $2.33M | 0.01% |
244,268
+17,443
| +8% | +$179K |
|
1463
TransUnion
TRU
$15.1B
| $2.32M | 0.01% |
60,594
+2,449
| +4% | +$86.1K |
|
1464
US Physical Therapy
USPH
$1.2B
| $2.32M | 0.01% |
35,539
+18,975
| +115% | +$1.34M |
|
1465
Element Solutions
ESI
$8.95B
| $2.32M | 0.01% |
178,171
+15,203
| +9% | +$187K |
|
|
TAHO
1466
DELISTED
Tahoe Resources Inc
TAHO
| $2.32M | 0.01% |
288,384
+21,406
| +8% | +$184K |
|
1467
Pricesmart
PSMT
$5.98B
| $2.31M | 0.01% |
25,094
+488
| +2% | +$42.8K |
|
|
GTLS
1468
DELISTED
Chart Industries
GTLS
| $2.3M | 0.01% |
65,797
+15,663
| +31% | +$580K |
|
|
SIR
1469
DELISTED
SELECT INCOME REIT
SIR
| $2.3M | 0.01% |
202,805
+14,817
| +8% | +$166K |
|
1470
Helix Energy Solutions
HLX
$1.4B
| $2.29M | 0.01% |
295,221
+105,183
| +55% | +$846K |
|
1471
Sturm, Ruger & Co
RGR
$594M
| $2.29M | 0.01% |
42,797
+11,046
| +35% | +$567K |
|
1472
Cal-Maine
CALM
$4.12B
| $2.29M | 0.01% |
62,158
+16,199
| +35% | +$648K |
|
|
BRKL
1473
DELISTED
Brookline Bancorp
BRKL
| $2.29M | 0.01% |
146,092
+961
| +0.7% | +$15.1K |
|
|
PTLA
1474
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.28M | 0.01% |
58,149
+3,097
| +6% | +$98.6K |
|
1475
Stewart Information Services
STC
$2.06B
| $2.27M | 0.01% |
51,300
+12,988
| +34% | +$572K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.